Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q3 2018 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks: does management convey that the deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago? We need to look for any statement from management that indicates an escalation in the unit size of their repeatable business. The transcript includes discussions about various segments: Plumbing, Decorative Architectural, Cabinetry, Windows. There is mention of growth, but we need to see if there is a specific statement about the size of individual deals or programs increasing. For example, in Cabinetry, they mention the Menards program. They say: "The roll-out and initial months of the Menards program have gone well, and we are on plan to achieve an $80 million annual sales run rate during the fourth quarter." That is about a new program, but is it about the size of the program being larger than previous ones? They don't compare it to past programs in terms of size. They also mention "our existing home center and dealer business experienced solid growth" but that's not about individual deal size. In Plumbing, they mention "Delta had a record sales quarter with strong growth across all channels and price points." That's about sales volume, not necessarily about individual orders being larger. In Decorative Architectural, they mention "high single-digit growth in pro paint and strong performance in decorative hardware" but again, that's about growth, not about the size of individual contracts. There is no mention of "average order size" or "larger contracts" or "customers starting at a broader scope" etc. The only thing that might be relevant is the Menards program, but they don't say that this program is larger than previous programs they've had. They just say it's on plan to achieve a certain run rate. They also mention "the roll-out and initial months of the Menards program have gone well" but no comparison to past programs. Also, they mention "our program at Menards continues to gain traction" but again, no comparison. The question specifically asks about "successive engagements of the same kind" coming in at progressively larger size. There is no such statement.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.